Arcutis Biotherapeutics (ARQT) Other Non Operating Income (2021 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Other Non Operating Income of -$20000.0 for Q1 2026, down 110.36% year-over-year from $193000.0 in Q1 2025, and up 99.69% quarter-over-quarter from -$6.4 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Other Non Operating Income (2021 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Other Non Operating Income history runs 6 years deep, the most recent figure standing at -$20000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income fell 110.36% year-over-year to -$20000.0; the TTM figure through Mar 2026 stood at -$2.3 million (up 39.35% YoY), while the FY2025 annual figure was $443000.0, up 842.55% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$20000.0, up from -$6.4 million in the prior quarter.
- The five-year high for Other Non Operating Income was $5.2 million in Q2 2024, with the low at -$13.4 million in Q4 2024.
- The 5-year median for Other Non Operating Income is $2.0 million (2025), against an average of $174000.0.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income surged 8400.0% in 2022, then sank 396.54% in 2023.
- Arcutis Biotherapeutics' Other Non Operating Income stood at $3.3 million in 2022, then sank by 396.54% to -$9.8 million in 2023, then sank by 36.19% to -$13.4 million in 2024, then surged by 52.13% to -$6.4 million in 2025, then jumped by 99.69% to -$20000.0 in 2026.
- Business Quant data shows ARQT's Other Non Operating Income at -$20000.0 in Q1 2026, -$6.4 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -157,000.00 |
| Mar 31, 2026 | -20,000.00 |
| Dec 31, 2025 | -6.42 Mn |
| Sep 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 193,000.00 |
| Dec 31, 2024 | -13.41 Mn |
| Sep 30, 2024 | 4.18 Mn |
| Jun 30, 2024 | 5.23 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Dec 31, 2023 | -9.85 Mn |
| Sep 30, 2023 | 2.72 Mn |
| Jun 30, 2023 | 3.12 Mn |
| Mar 31, 2023 | 3.21 Mn |
| Dec 31, 2022 | 3.32 Mn |
| Sep 30, 2022 | 1.94 Mn |
| Jun 30, 2022 | 421,000.00 |
| Mar 31, 2022 | 142,000.00 |
| Dec 31, 2021 | -40,000.00 |
| Sep 30, 2021 | 98,000.00 |